As the Super Bowl approaches, the cost of a 30-second commercial spot has reached an unprecedented $10 million, driven by intense demand and bundled packages with the Olympics. Major brands are betting big with celebrity-studded campaigns, but analysts question the long-term value of such staggering investments.
Elon Musk is set to combine his aerospace giant SpaceX with his artificial intelligence venture xAI, creating a single entity valued at $1.25 trillion ahead of a highly anticipated IPO later this year, according to a Bloomberg report.
As economic anxieties mount, strategic diversification remains paramount. We examine two Vanguard ETFs that could offer stability and long-term growth opportunities should market conditions deteriorate.
Despite recent sharp declines triggered by Fed nomination news, JPMorgan analysts reaffirm a bullish $6,300 per ounce gold target for 2026, citing resilient demand from central banks and investors.
A significant reset in analyst price targets for iRhythm Holdings (IRTC) is prompting investors to reassess the cardiac monitoring firm's risk-reward profile. This shift reflects evolving views on reimbursement headwinds, competitive pressures, and long-term growth catalysts in the digital health sector.
Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
CNBC's Jim Cramer lauds Salesforce's operational strength, yet the stock, alongside peer ServiceNow, faces persistent 'multiple compression' as Wall Street reevaluates growth expectations for mature software leaders.
As AMD prepares to report its Q4 2025 results, robust data center demand and ramping MI350 AI chip deployments paint a bullish picture. Yet, heavy investment costs and a history of post-earnings stock dips suggest investors should temper expectations.
A recent adjustment to Airgain's price target by analysts reflects a broader reassessment of the wireless connectivity specialist's prospects, underscoring how evolving narratives, rather than single events, are reshaping investor views on the stock.
IDEAYA Biosciences shares have retreated from recent highs, sparking debate among investors. While a discounted cash flow model suggests deep undervaluation, price-to-sales metrics paint a contrasting picture of a premium stock. We examine the numbers behind the volatility and what it signals for the precision oncology company's future.
Alliance Resource Partners (ARLP) posted a significant jump in fourth-quarter profit, driven by cost controls and investment gains, even as coal revenue softened. The partnership issued 2026 guidance pointing to robust contract coverage and a growing oil & gas royalty segment, while navigating challenges at a key Appalachian mine.
After a prolonged downturn, the pre-owned watch market saw a modest rebound in late 2025, driven largely by Patek Philippe and Rolex. However, a new report reveals a stark divide, with most brands still struggling with value retention as consumers pivot towards pragmatic purchases.
In a pivotal move, Syrian government forces have deployed in the northeastern city of Hasakah, following a U.S.-backed agreement with the Kurdish-led Syrian Democratic Forces (SDF) to integrate their forces, signaling a major realignment in the war-torn region.
Climate Impact Partners bolsters its leadership team with the appointment of Ryan King, former CCO of carbon removal firm Undo Carbon, signaling aggressive expansion plans in the evolving voluntary carbon market.
Sony Group's shares have faced significant headwinds, declining over 15% in the past month. As the stock hovers around ¥3,397, analysts are divided on whether this represents a buying opportunity or a sign of deeper challenges in its gaming and sensor divisions.
Tether, the company behind the world's dominant stablecoin, has quietly built a balance sheet rivaling major financial institutions, amassing vast holdings of U.S. Treasury debt and gold. Its explosive growth is reshaping its role in traditional finance and drawing regulatory scrutiny.
While Colgate-Palmolive's stock has trailed the S&P 500 over the past year, Wall Street analysts see a resilient business model and strong international presence supporting long-term growth, maintaining a 'Moderate Buy' consensus.
Despite Dell Technologies' strategic push into AI infrastructure and analyst endorsements, its stock continues to underperform the broader market, raising questions about the timing of its promised turnaround.
Africa's used vehicle market is on track to expand at nearly 7% annually, approaching a $200 billion valuation by 2033, as demand for affordable personal transport surges across the continent.
While broader UK indices face headwinds, a closer look reveals potential in smaller-cap companies. We examine three penny stocks—Alumasc Group, Mercia Asset Management, and Roebuck Food Group—that are navigating economic challenges with distinct strategies and financial profiles.
